States Sue Abbott Over Its “Scheme” To Block Generic TriCor Competition

Eighteen states and the District of Columbia filed an antitrust suit against Abbott and its marketing partner Fournier claiming they illegally blocked generic competition for TriCor (fenofibrate) by making minor changes in the drug's formulation and filing baseless patent infringement suits